Beyond apoptosis: Annexin A5 as a multifunctional regulator in the pathophysiology of diabetes and its complications
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2026-11 · 1872 (8) · 168385
DOI: 10.1016/j.bbadis.2026.168385 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2026-11. Verfasst von Zamzam Farhan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Medical and Health Sciences (RIMHS), Sharjah, 27272, University of Sharjah, United Arab Emirates. Hauptthemen laut MEDLINE: Annexin A5, Apoptosis, Diabetes Mellitus, Diabetes Complications. Die Arbeit nennt 108 Literaturangaben. Gefördert von: University of Sharjah.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Annexin A5 (ANXA5) is a Ca2+-dependent phosphatidylserine (PS)-binding protein classically employed as an apoptosis biomarker. Accumulating evidence now positions ANXA5 as a multifunctional regulator of membrane homeostasis, immunometabolism, and cellular adaptation to metabolic stress across the spectrum of diabetes mellitus (DM). This review synthesizes current mechanistic and translational insights identifying ANXA5 as a candidate molecular determinant of diabetic pathophysiology. Its conserved α-helical architecture and dual-promoter transcriptional regulation enable reversible, high-affinity PS binding and assembly of a two-dimensional (2D) crystalline lattice that underpins its diverse biological functions. In the pancreas, ANXA5 has been shown to inhibit islet amyloid polypeptide (IAPP) aggregation and shields β-cell membranes from amyloid-induced injury; it has also been proposed to modulate mitochondrial Ca2+ homeostasis via VDAC1-associated pathways. In insulin-responsive peripheral tissues, ANXA5 has been hypothesized to modulate insulin signaling fidelity and facilitate glucose uptake through putative IRS-1 interactions and lipid raft stabilization, although direct in vivo validation remains outstanding. In the diabetic endothelium, hyperglycemia-induced dysfunction of acid sphingomyelinase impairs ANXA5-mediated membrane resealing, thereby precipitating Ca2+ overload, inflammasome activation, and a prothrombotic state. Experimental studies further suggest that ANXA5 may promote M2 macrophage polarization and suppress TGF-β/Smad2/3 signaling, indicating potential roles in immunomodulation and fibrosis attenuation. Importantly, distinct disease contexts shape ANXA5 biology: in T2D, glucolipotoxic stress and IAPP aggregation drive ANXA5-dependent protective responses, whereas in T1D, circulating anti-ANXA5 autoantibodies may neutralize membrane-protective functions and amplify vascular injury risk. Emerging translational applications include recombinant ANXA5 (NEXUS) and Diannexin, although prospective clinical validation remains limited. To facilitate interpretation of the literature, we introduce an evidence-grading framework that distinguishes diabetes-validated mechanisms from biologically supported, incompletely validated, and speculative pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Institute for Medical and Health Sciences (RIMHS), Sharjah, 27272, University of Sharjah, United Arab Emirates.
- College of Medicine, Department of Basic Medical Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates; Research Institute for Medical and Health Sciences (RIMHS), Sharjah, 27272, University of Sharjah,…
Förderung
- University of Sharjah
Zitieren
APA
Farhan, Z., Saeed, R., Mahgoub, E., Khalique, A., & Taneera, J. (2026). Beyond apoptosis: Annexin A5 as a multifunctional regulator in the pathophysiology of diabetes and its complications. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1872(8), 168385. https://doi.org/10.1016/j.bbadis.2026.168385
Vancouver
Farhan Z, Saeed R, Mahgoub E, Khalique A, Taneera J. Beyond apoptosis: Annexin A5 as a multifunctional regulator in the pathophysiology of diabetes and its complications. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2026;1872(8):168385. doi:10.1016/j.bbadis.2026.168385
BibTeX
@article{Farhan2026,
author = {Farhan, Zamzam and Saeed, Rania and Mahgoub, Eglal and Khalique, Anila and Taneera, Jalal},
title = {Beyond apoptosis: Annexin A5 as a multifunctional regulator in the pathophysiology of diabetes and its complications},
journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
year = {2026},
volume = {1872},
number = {8},
pages = {168385},
doi = {10.1016/j.bbadis.2026.168385}
}
EUVIMED